-
Assessing the Impact of Digital Ecosystem Engagement on Outcomes in Sickle Cell Disease (SCD) Patients
Mar 10, 2025, 14:00 PM -
The Relationship Between Progression-Free Survival and Overall Survival in Relapsed/Refractory Multiple Myeloma: A Meta-Regression of Clinical Trial Data
Mar 10, 2025, 14:00 PM -
Predictive Modeling for Designing a Personalized Statin Therapy: Optimizing Treatment Efficacy in Cardiovascular Disease Prevention
Mar 10, 2025, 14:00 PM -
Economic and Clinical Burden of Recurrence Among Elderly Patients With Resected Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA HNSCC) in the US
Mar 10, 2025, 14:00 PM -
Analysis of Patient Pathway on In Vitro Fertilization Treatment in Hungary
Mar 10, 2025, 14:00 PM -
Baseline BMI and HbA1c Trends in US Diabetic Patients Initiating GLP-1 Therapy: A Retrospective Cohort Study
Mar 10, 2025, 14:00 PM -
Utilization of Overall Survival and Other Survival Endpoints in Clinical Trials for Adjuvant Therapies in Resectable Tumors
Mar 10, 2025, 14:00 PM -
Emerging Trends in List Price Adjustment Strategies Following Implementation of the Inflation Reduction Act
Mar 10, 2025, 14:00 PM -
Validation of a Questionnaire to Evaluate Simplicity of Diabetes Treatment (SIM-Q)
Mar 10, 2025, 14:00 PM -
Precision Medicine Enabled Benefits Management for Oral Diabetes and Weight Loss Management
Mar 10, 2025, 14:00 PM -
Differential Effect of Transdiagnostic Cognitive-Behaviour Therapy on Health-Related Quality of Life According to the Number of Anxiety Comorbidities
Mar 10, 2025, 14:00 PM -
Economic Savings Associated with Surgical Mitral Valve Replacement with a Novel Bovine Bioprosthesis
Mar 10, 2025, 14:00 PM -
Health Care Resource Utilization (HCRU), and Direct Medical Costs Among Patients With Locally Advanced or Metastatic HER2 Negative Gastric Cancer (GC) in the United States.
Mar 10, 2025, 14:00 PM -
Assessing the Feasibility of Using an Electronic Platform for Personalized Outcome Assessment: GoalNav for Goal Attainment Scaling
Mar 10, 2025, 14:00 PM -
Comparison of Central Venous Access Device Insertion Proportions, Costs and Removal Time Between Subcutaneous and Intravenous Formulations of Pertuzumab and Trastuzumab in HER2+ Early Breast Cancer Patients
Mar 10, 2025, 14:00 PM -
Indirect Treatment Comparison (ITC) of Mirdametinib and Selumetinib for the Treatment of Children with Neurofibromatosis Type 1-Associated Plexiform Neurofibromas (NF1-PN)
Mar 10, 2025, 14:00 PM -
Analysis of the Burden of Illness, Treatment, and Health Disparities in Amyotrophic Lateral Sclerosis
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization and Costs of Schizophrenia Among Medicaid Beneficiaries
Mar 10, 2025, 14:00 PM -
Epidemiological Insights in Cornelia-de-Lange Syndrome: A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Impact of Procedure Wait Times on One-Year Health Outcomes in Patients With Degenerative Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge Repair
Mar 10, 2025, 14:00 PM
